Nolwen L Rey Selected Research

Synucleinopathies

1/2021	T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils.
12/2019	α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb.
1/2019	Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy.
1/2018	Biochemical Profiling of the Brain and Blood Metabolome in a Mouse Model of Prodromal Parkinson's Disease Reveals Distinct Metabolic Profiles.
11/2014	The role of Galectin-3 in α-synuclein-induced microglial activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nolwen L Rey Research Topics

Disease

9	Parkinson Disease (Parkinson's Disease) 01/2021 - 04/2013
5	Synucleinopathies 01/2021 - 11/2014
2	Multiple System Atrophy 01/2021 - 03/2014
2	Disease Progression 01/2018 - 04/2013
2	Inflammation (Inflammations) 11/2014 - 04/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Neuroinflammatory Diseases 04/2013
1	Memory Disorders (Memory Loss) 02/2012

Drug/Important Bio-Agent (IBA)

9	SynucleinsIBA 01/2021 - 04/2013
3	PrionsIBA 01/2018 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2019
1	alpha-SynucleinIBA 12/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 10/2018
1	Protein AggregatesIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Galectin 3 (LGALS3)IBA 11/2014
1	saccharide-binding proteinsIBA 11/2014
1	Messenger RNA (mRNA)IBA 03/2014
1	DSP 4 (DSP-4)IBA 02/2012

Therapy/Procedure

1	Therapeutics 04/2013